Código 2936 (Harmonized System 2012 by 4 digits)
2023: US$193M, Total Trade Exchange
2023: US$17.7M, International Sales
2023: US$175M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent was US$193M.
In 2023, the states with the most international sales in Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent were Jalisco (US$10.3M), Estado de México (US$4.06M), Querétaro (US$2.77M), Ciudad de México (US$400k), and Nuevo León (US$41.1k).
The states with the most international purchases in 2023 were Jalisco (US$93M), Ciudad de México (US$47.7M), Querétaro (US$17M), Estado de México (US$8.38M), and Nuevo León (US$3.33M).
In 2023, the main commercial destinations of Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent were Guatemala (US$7.03M), United States (US$1.3M), Brazil (US$1.2M), Colombia (US$1.11M), and Costa Rica (US$1.04M).
The main commercial origins of Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent in 2023 were China (US$70.5M), Germany (US$27.9M), United States (US$22.6M), France (US$18.8M), and Switzerland (US$14.3M).
In the global context, the main exporting countries of Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent in 2022 were China (US$3.84B), Germany (US$1.09B), and Netherlands (US$991M). In the same year, the main importing countries of Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent were United States (US$1.6B), Germany (US$777M), and Netherlands (US$654M).
US$193M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent in Mexico (including international purchases and sales) was US$193M.
The visualizations show the net balance of Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
2024-Q3: US$307k, International Sales
The visualization shows the quarterly concentration of international sales of Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent at state level.
In the third quarter of 2024, international sales were US$307k, being the states with the most sales Estado de México (US$307k).
Jalisco: US$10.3M, State with the Most International Sales (2023)
Guatemala: US$7.03M, Main commercial destination (2023)
In 2023, the states with the highest international sales in Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent were Jalisco (US$10.3M), Estado de México (US$4.06M), Querétaro (US$2.77M), Ciudad de México (US$400k), and Nuevo León (US$41.1k).
In 2023, the countries with the most international purchases from Mexico were Guatemala (US$7.03M), United States (US$1.3M), Brazil (US$1.2M), Colombia (US$1.11M), and Costa Rica (US$1.04M).
Jalisco: US$93M, State with the Most International Purchases (2023)
China: US$70.5M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent were Jalisco (US$93M), Ciudad de México (US$47.7M), Querétaro (US$17M), Estado de México (US$8.38M), and Nuevo León (US$3.33M).
The countries with the most international sales to Mexico in 2023 were China (US$70.5M), Germany (US$27.9M), United States (US$22.6M), France (US$18.8M), and Switzerland (US$14.3M).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent were China (US$3.84B), Germany (US$1.09B), and Netherlands (US$991M). In the same year, the main importing countries for Provitamins and Vitamins, Natural or Reproduced by Synthesis (Including Natural Concentrates), Derivatives Thereof Used Primarily as Vitamins, Mixed or Yes or any Solvent were United States (US$1.6B), Germany (US$777M), and Netherlands (US$654M).